The US equity markets ended with a mixed session after New York City Mayor Bill de Blasio warned the city could see a full shutdown in the weeks ahead due to a surge in COVID-19 infections and as OPEC cut its oil demand forecast.

Boston Mayor Marty Walsh separately announced the city is rolling back to Phase 2, Step 2 effective Wednesday.

It will close gyms and fitness centers, along with theaters and museums, for around three weeks.

The Dow Jones Industrial Average ended down over 186 points or 0.62%, paring an early gain of as much as 270 points that came as the first batch of COVID-19 vaccines delivered and as bipartisan stimulus deal talks showed signs of progress.The S 500 also fell, ending 0.44% lower as energy stocks tumbled after OPEC trimmed its 2021 demand forecast by 350,000 barrels per day.

Tesla Inc., which will be added to the S 500 on Friday, was among the index’s leaders.

The vaccine will be delivered by FedEx Corp. to 145 U.S. hospitals Monday, followed by another 425 on Tuesday and 66 on Wednesday.

Summary- A new market study, titled “Global Coronavirus (COVID 19) Vaccine Market Research Report 2020”has been featured on Wiseguy Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

Key trends in terms of collaboration and partnership deals are analyzed with details.Also Read: https://www.medgadget.com/2020/08/insights-on-the-coronavirus-covid-19-vaccine-market-2020-key-players-data-revenue-future-development-trend-and-forecast-by-2026.htmlThe report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market.

Summary – A new market study, “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020”has been featured on WiseGuyReports.“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

Key trends in terms of collaboration and partnership deals are analyzed with details.Also Read: https://www.medgadget.com/2020/08/insights-on-the-coronavirus-covid-19-vaccine-market-2020-key-players-data-revenue-future-development-trend-and-forecast-by-2026.htmlThe report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market.

The report delivers crucial data in the form of tables, charts, graphs and figures in a comprehensive study of the Coronavirus Vaccines Pipeline Analysis.Download Free Sample Report @ https://dpiresearch.com/request-a-free-sample-report/“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

The key players are evaluated on the various parameters such as business overview, promising vaccine in clinical development, and recent development.Report Scope:Extensive coverage of the Coronavirus (COVID-19) vaccine under developmentDetailed Insights of the Introduction, Pathogen Characteristics, Signs and Symptoms, Transmission and PreventionProvides Comprehensive Insights on the Funding of the Coronavirus (COVID-19) Vaccine ResearchThoroughly Evaluates Vaccines Developed Against MERS-CoV and SARS-CoVReviews Most Recent Clinical Trials of the Coronavirus VaccinesScrutinizes Countries, Territories or Areas with Reported Laboratory-Confirmed Coronavirus (COVID-19) Cases and DeathsProvides Key Trends with Respect to Collaboration and Partnership DealsAn Insightful Analysis of the Key Vaccine Developers Along with the Analysis of their Promising Vaccines in the Clinical Development, Phase, Platform Technology, and Recent DevelopmentEnquire for customization in Report @: https://dpiresearch.com/services/custom-research-services-providing-focused-comprehensive-tailored-research/Key Vaccine Developers Covered in the ReportUniversity of OxfordClover Biopharmaceuticals/Dynavax/GlaxoSmithKlineHeat Biologics Inc./University of MiamiInovio Pharmaceuticals IncJanssen PharmaceuticalSanofi Pasteur/GlaxoSmithKline (GSK)Moderna/NIAIDNovavaxSanofi Pasteur/Translate Bio Inc.Vaxart Inc.AltimmuneMedicagoBioNTech/Pfizer/Fosun PharmaGeoVax/BravoVaxArcturus Therapeutics/Duke-NUSCanSino Biological Inc/Beijing Institute of BiotechnologyTakis Biotech/Applied DNA Sciences/EvvivaxCobra Biologics/Karolinska InstituteZydus CadilaCodagenix/Serum Institute of IndiaGreffexExpreS2ion Biotechnologies ApSVaxil Bio TherapeuticsFlow Pharma IncAJ VaccinesGenerex Biotechnology/EpiVaxImmunomic Therapeutics/EpiVax/PharmaJetiBio Inc/CC-Pharming Ltd/Infectious Disease Research InstituteVIDO-InterVac/University of Saskatchewan/International Vaccine InstituteTonix Pharmaceuticals/Southern ResearchIAVI/Batavia BiosciencesCurevacImophoron Ltd/University of BristolBioNet AsiaSinovac/DynavaxBIOCADUniversity of PittsburghFor More Information@ https://dpiresearch.com/reports/coronavirus-covid-19-vaccine/The report is readily available and can be dispatched immediately after payment confirmation.Would like to place an order or any question, please feel free to contact at [email protected] of the Report:DPI Research provides customization of the report as per your need.

Get in touch with our sales team, who will guarantee you to get a report that suits your necessities.Contact Us:Maria RaiHead of Business DevelopmentDPI Research | Web: https://dpiresearch.comDirect Line: +91-766-764-8693E-mail: [email protected] Us:DPI Research is a leading market research publisher which offer bespoke market research reports, custom research and consulting services across multi geographies and industry verticals.

Summary- A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on Wiseguy Reports“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

The report also offers comprehensive information about the recruiting clinical trials statement by phase, trial status, study sponsor name, and study phase.

Summary - A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on WiseGuyReports.

“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

Summary- A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on Wiseguy Reports “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

The report also offers comprehensive information about the recruiting clinical trials statement by phase, trial status, study sponsor name, and study phase.

Summary - A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on WiseGuyReports.“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

ALSO READ: https://www.medgadget.com/2020/08/insights-on-the-coronavirus-covid-19-vaccine-market-2020-key-players-data-revenue-future-development-trend-and-forecast-by-2026.html The report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market.

Summary - A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on WiseGuyReports.

“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

ALSO READ: https://www.medgadget.com/2020/08/insights-on-the-coronavirus-covid-19-vaccine-market-2020-key-players-data-revenue-future-development-trend-and-forecast-by-2026.html The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

Summary - A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on WiseGuyReports.“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

Key trends in terms of collaboration and partnership deals are analyzed with details.Also Read: https://www.medgadget.com/2020/08/insights-on-the-coronavirus-covid-19-vaccine-market-2020-key-players-data-revenue-future-development-trend-and-forecast-by-2026.htmlThe report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market.

Summary – A New Market Study, “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” Has Been Featured On Wiseguyreports.“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.Also Read : https://www.medgadget.com/2020/08/insights-on-the-coronavirus-covid-19-vaccine-market-2020-key-players-data-revenue-future-development-trend-and-forecast-by-2026.html The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

The report also offers comprehensive information about the recruiting clinical trials statement by phase, trial status, study sponsor name, and study phase.

Key trends in terms of collaboration and partnership deals are analyzed with details.Also Read : https://www.newsmaker.com.au/news/379562/global-bcg-vaccine-consumption-market-analysis-2020-forecasts-to-2025#.X3xJmqBR3IU The report concludes with the profiles of the key vaccine developers in the global coronavirus vaccine market.

Summary - A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on WiseGuyReports.“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

The report also offers comprehensive information about the recruiting clinical trials statement by phase, trial status, study sponsor name, and study phase.

Summary - A new market study, titled “Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” has been featured on WiseGuyReports.

“Coronavirus (COVID 19) Vaccine Pipeline Assessment 2020” provides a comprehensive analysis of the fast-evolving, high-growth global Coronavirus (COVID 19) vaccine market.

The report offers the most up-to-date industry data on the actual market situation for the Coronavirus (COVID 19) vaccine.

ALSO READ: https://www.medgadget.com/2020/08/insights-on-the-coronavirus-covid-19-vaccine-market-2020-key-players-data-revenue-future-development-trend-and-forecast-by-2026.html The report explores a detailed analysis of the introduction of the coronavirus, pathogen characteristics, signs and symptoms, transmission, and prevention.

It also evaluates the vaccines developed against MERS-CoV and SARS-CoV.

The report reviews a clear insight into the funding of the Coronavirus (COVID-19) vaccine research.

On Aug, 15, the U.S. Food and Drug Administration amended the emergency use authorizations (EUAs) for both the Pfizer-BioNTech COVID-19 Vaccine and the Moderna COVID-19 Vaccine to allow for the use of an additional dose in certain immunocompromised individuals, specifically, solid organ transplant recipients or those who are diagnosed with conditions that are considered to have an equivalent level of immunocompromise.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices is scheduled to meet Friday to discuss further clinical recommendations regarding immunocompromised individuals.

Today’s action does not apply to people who are not immunocompromised.

“The country has entered yet another wave of the COVID-19 pandemic, and the FDA is especially cognizant that immunocompromised people are particularly at risk for severe disease.

After a thorough review of the available data, the FDA determined that this small, vulnerable group may benefit from a third dose of the Pfizer-BioNTech or Moderna Vaccines,” said Acting FDA Commissioner Janet Woodcock, M.D.

As we’ve previously stated, other individuals who are fully vaccinated are adequately protected and do not need an additional dose of COVID-19 vaccine at this time.